Frequency and outcomes of treatment dose escalation with biologics in moderate-to-severe psoriasis: a Swedish register study

• Main Authors: Axel Svedbom (Author), Christina Wennerström (Author), Fredrik Hjelm (Author), Anna Tjärnlund (Author), Mona Ståhle (Author)
• Format: Bog
• Udgivet: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Background The advent of biosimilars may increase the frequency of dose escalation with biologics in psoriasis.Objective To explore the frequency and outcomes of dose escalation with adalimumab etanercept, and ustekinumab.Methods Data were extracted from DermaReg-Pso, a psoriasis register in Stockho...